Lucy Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
Lucy Therapeutics is a private biotechnology company based in Waltham, Massachusetts, focused on developing proprietary small molecule therapies and diagnostic biomarkers. It combines knowledge mapping with mitochondrial biology to identify and pursue targets at the intersection of genetic, mitochondrial, and environmental dysfunction in complex diseases. Its initial CNS programs target Rett Syndrome and Parkinson's disease, and the associated targets have shown neuroprotective activity in multiple animal models with development candidates identified for both. In October 2024, Lucy Therapeutics announced the appointment of Kim Drapkin as Board Chair, a governance change aligned with advancing its programs toward clinical evaluation. The company remains a small, private biotechnology research entity based in Waltham, Massachusetts.